NetraMark Raises $3.11 Million in First Tranche of Private Placement

The latest update is out from NetraMark Holdings ( (TSE:AIAI) ).

NetraMark Holdings has closed the first tranche of its non-brokered private placement, raising gross proceeds of $3.11 million through the issuance of 3,110,000 units priced at $1.00 each, with attached warrants exercisable at $1.35 for two years and subject to a standard hold period, bringing the company’s total outstanding common shares to 91,778,520. The company has also secured commitments for the second and final tranche of $390,000, with the total proceeds earmarked for working capital and general corporate purposes, and insider participation structured under available exemptions from formal valuation and minority approval rules, underscoring both continued internal support and the capital needed to advance its AI-driven clinical trial analytics platform in the pharmaceutical sector.

More about NetraMark Holdings

NetraMark Holdings is an artificial intelligence company focused on developing generative AI and machine learning solutions for the pharmaceutical industry, with its NetraAI platform designed to improve clinical trial outcomes by parsing even small patient datasets into meaningful, explainable subsets to better segment diseases and predict treatment response and drug sensitivity.

Average Trading Volume: 51,752

Technical Sentiment Signal: Buy

Current Market Cap: C$94.43M

For detailed information about AIAI stock, go to TipRanks’ Stock Analysis page.